ASRS
SYRE icon

Arizona State Retirement System’s Spyre Therapeutics SYRE Stock Holding History

Arizona State Retirement System’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Buy
15,471
+2,033
+15% +$148K 0.01% 978
2026
Q1 		$678K Sell
13,438
-359
-3% -$13.5K ﹤0.01% 1313
2025
Q4 		$452K Buy
13,797
+3,104
+29% +$81.1K ﹤0.01% 1536
2025
Q3 		$179K Buy
10,693
+181
+2% +$2.95K ﹤0.01% 1985
2025
Q2 		$157K Buy
10,512
+495
+5% +$7.32K ﹤0.01% 1963
2025
Q1 		$162K Sell
10,017
-98
-1% -$2.04K ﹤0.01% 1937
2024
Q4 		$235K Buy
10,115
+2,805
+38% +$82.3K ﹤0.01% 1877
2024
Q3 		$215K Buy
+7,310
New +$204K ﹤0.01% 1930
2024
Q2 		– Sell
-5,445
Closed -$207K – 2151
2024
Q1 		$207K Buy
+5,445
New +$158K ﹤0.01% 1908

Other funds holding SYRE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Arizona State Retirement System's SYRE Position: Q2 2026 in Review

Arizona State Retirement System increased its Spyre Therapeutics (SYRE) stake by 15% in Q2 2026, buying an estimated $148K and bringing the position to 15,471 shares worth $1.37M. The position accounts for 0.01% of the portfolio, ranked #978.

Arizona State Retirement System first reported a position in SYRE in Q1 2024 and has held it in 9 quarters since. 265 funds tracked by Wall St. Rank hold SYRE as of Q2 2026.

  • Arizona State Retirement System held 15,471 shares of Spyre Therapeutics worth $1.37M as of Q2 2026.
  • Arizona State Retirement System bought 2,033 Spyre Therapeutics shares in Q2 2026, an estimated $148K.
  • Spyre Therapeutics made up 0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #978 holding.
  • Arizona State Retirement System first reported a position in Spyre Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 265 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.